Related Experiment Video
Updated: May 1, 2026

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
Current concepts of pheochromocytoma
Giovanni Conzo1, Daniela Pasquali2, Vittorio Colantuoni3
1Department of Anaesthesiologic, Surgical and Emergency Science, VII Division of General and Endocrine Surgery, Second University of Naples, Via Gen. Giordano Orsini 42, 80132 Naples, Italy.
Pheochromocytoma (PCC) is a rare tumor. Updates in genetics and surgical management, including minimally invasive adrenalectomy, improve patient outcomes and lifelong risk assessment.
Area of Science:
- Endocrinology
- Oncology
- Genetics
Background:
- Pheochromocytoma (PCC) is a rare neuroendocrine tumor, found in 0.1-0.6% of hypertensive patients.
- Increasing diagnoses of hereditary and subclinical PCCs necessitate updated management strategies.
- The
- rule of 10
- highlights key characteristics: 10% malignant, 10% bilateral, 10% extra-adrenal, 10% familial.
Purpose of the Study:
- To review current controversies and recent advancements in pheochromocytoma management.
- To focus on updates in inheritance genetics and surgical interventions.
- To emphasize the role of genetic testing in long-term risk stratification.
Main Methods:
- Literature review focusing on recent updates in PCC genetics and surgical management.
- Analysis of preoperative treatment protocols, including alpha-blockers and beta-blockers.
- Evaluation of minimally invasive adrenalectomy techniques versus traditional surgery.
Main Results:
- Surgical resection is the only curative treatment but carries risks of hypertensive crises.
- Minimally invasive adrenalectomy (laparoscopic, retro-peritoneoscopic) offers faster recovery and reduced complications for tumors ≤6 cm.
- Alpha-blocker therapy is standard preoperative care, often combined with other agents.
Conclusions:
- Minimally invasive adrenalectomy is the gold standard for resectable PCCs.
- Genetic testing is crucial for predicting lifelong risks of recurrence, contralateral disease, or malignant transformation.
- Updated follow-up protocols informed by genetic testing are essential for comprehensive PCC patient care.
Related Concept Videos
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Cushing Syndrome II: Pathophysiology
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Adrenergic Neurons: Neurotransmission
Synthesis: Catecholamine synthesis requires tyrosine, which...
Sympathetic Pathways: Collateral Ganglia and Adrenal Medulla
Collateral Ganglia
Sympathetic preganglionic axons reach the collateral ganglia along the route of splanchnic nerves. These nerves bypass the sympathetic trunk and communicate with sympathetic postganglionic neurons housed in the prevertebral ganglia. These ganglia supply the organs of the abdominopelvic cavity.
The greater splanchnic nerve, formed by the...
Cushing Syndrome I: Introduction

